OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ATXS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Astria Therapeutics (ATXS) Earnings Date & Reports

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ATXS is expected to report earnings to rise 5.75% to -60 cents per share on November 12

Astria Therapeutics ATXS Stock Earnings Reports

Q3'25

Est.

$-0.60

Q2'25

Missed

by $0.08

Q1'25

Missed

by $0.13

Q4'24

Beat

by $0.01

Q3'24

Est.

$-0.42

The last earnings report on August 12 showed earnings per share of -56 cents, missing the estimate of -49 cents. With 414.11K shares outstanding, the current market capitalization sits at 381.50M.

View a ticker or compare two or three

Compare

ATXS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ATXS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ATXS showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

75 State Street

Phone

+1 617 349-1971

Employees

Web

https://www.astriatx.com